Search
Descriptor English: Neurotransmitter Uptake Inhibitors
Descriptor Spanish: Inhibidores de la Captación de Neurotransmisores
Descriptor inhibidores de la captación de neurotransmisores
Entry term(s) inhibidor de la captación de neurotransmisores
inhibidor de la recaptación de neurotransmisores
inhibidores de la captación de transmisores neuronales
inhibidores de la recaptación de neurotransmisores
Scope note: Fármacos que inhiben el transporte de neurotransmisores hacia el interior de las terminales axónicas o hacia las vesículas de almacenamiento que están en las terminales. En el caso de muchos transmisores, la captación determina su periodo de acción, de modo que al inhibir la captación se prolonga la actividad del transmisor. El bloqueo de la captación puede también reducir los depósitos disponibles del trasmiso. Muchos fármacos importantes desde el punto de vista clínico son inhibidores de la captación, aunque a menudo son las reacciones indirectas sobre el cerebro, más que el propio bloqueo agudo de la captación, las responsables de los efectos terapéuticos.
Descriptor Portuguese: Inibidores da Captação de Neurotransmissores
Descriptor French: Inhibiteurs de la capture des neurotransmetteurs
Entry term(s): Inhibitors, Neurotransmitter Reuptake
Inhibitors, Neurotransmitter Uptake
Neurotransmitter Reuptake Inhibitors
Reuptake Inhibitors, Neurotransmitter
Transmitter Uptake Inhibitors, Neuronal
Uptake Inhibitors, Neurotransmitter
Tree number(s): D27.505.519.562.437
D27.505.519.625.600
D27.505.696.577.600
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014179
Scope note: Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
Annotation: general or unspecified; prefer specific groups or specific drugs; coordinate with specific neurotransmitters /physiol
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Cytoplasmic Granules (1966-1977)
Kinetics (1966-1984)
Nerve Endings (1966-1973)
Synapses (1966-1971)
Synaptic Vesicles (1972-1973)
Synaptosomes (1974-1984)
Public MeSH Note: 93; was TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92
Online Note: use NEUROTRANSMITTER UPTAKE INHIBITORS to search TRANSMITTER UPTAKE INHIBITORS, NEURONAL; INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER 1985-92
History Note: 93; WAS TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92
Entry Version: NEUROTRANSM UPTAKE INHIB
DeCS ID: 30902
Unique ID: D014179
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1985/01/01
Date of Entry: 1984/05/01
Revision Date: 2005/06/30
Neurotransmitter Uptake Inhibitors - Preferred
Concept UI M0021830
Scope note Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
Preferred term Neurotransmitter Uptake Inhibitors
Entry term(s) Inhibitors, Neurotransmitter Reuptake
Inhibitors, Neurotransmitter Uptake
Neurotransmitter Reuptake Inhibitors
Reuptake Inhibitors, Neurotransmitter
Transmitter Uptake Inhibitors, Neuronal
Uptake Inhibitors, Neurotransmitter



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey